Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

National Institute of Environmental Health Sciences

Use this QR code to view the newest version of this document
Use this QR code to view the newest version of this document

Your Environment. Your Health.

Publication Detail

Title: Enhancement by butylated hydroxytoluene of the in vitro activation of 3,3'-dichlorobenzidine.

Authors: Ghosal, A; Iba, M M

Published In Mutat Res, (1992 Jan)

Abstract: Mutagenicity of Salmonella TA98 and covalent binding to DNA of 3,3'-dichlorobenzidine (DCB) were used to assess the influence of di-tert.-butylated hydroxytoluene (BHT) on the in vitro activation of the arylamine by rat hepatic S9 metabolic systems. BHT at a concentration of 4 or 20 microM enhanced the mutagenicity of DCB by 32 or 21%, respectively, and the covalent binding of DCB to added DNA by 76 or 328%, respectively. The antioxidant altered the HPLC profile of isolable DCB metabolites, causing a decrease in the formation of three metabolites, an increase in the formation of one metabolite, and the formation of an entirely new metabolite. BHT inhibited the mutagenicity of the promutagen 2-acetylaminofluorene (2-AAF) but had no effect on that of the direct-acting mutagen 2,4- dinitrophenylhydrazine (DNPH). The results show that BHT enhances the mutagenicity of and DNA binding by DCB, in contrast with the predominantly inhibitory effect of the antioxidant on the mutagenicity of other chemicals that require bioactivation.

PubMed ID: 1370117 Exiting the NIEHS site

MeSH Terms: 3,3'-Dichlorobenzidine/metabolism*; 3,3'-Dichlorobenzidine/pharmacology; Animals; Biotransformation; Butylated Hydroxytoluene/pharmacology*; DNA/metabolism; Kinetics; Microsomes, Liver/drug effects; Microsomes, Liver/metabolism*; Mutagenicity Tests; Rats; Salmonella typhimurium/drug effects

Back
to Top